Tatiana A. Slastnikova

ORCID: 0000-0003-1718-5577
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • RNA Interference and Gene Delivery
  • Advanced biosensing and bioanalysis techniques
  • Radiopharmaceutical Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • Antioxidant Activity and Oxidative Stress
  • Genomics, phytochemicals, and oxidative stress
  • Photosynthetic Processes and Mechanisms
  • Adenosine and Purinergic Signaling
  • Viral Infectious Diseases and Gene Expression in Insects
  • melanin and skin pigmentation
  • Metal-Organic Frameworks: Synthesis and Applications
  • SARS-CoV-2 and COVID-19 Research
  • HER2/EGFR in Cancer Research
  • Free Radicals and Antioxidants
  • Immunotherapy and Immune Responses
  • Quantum-Dot Cellular Automata
  • DNA and Nucleic Acid Chemistry
  • Algal biology and biofuel production
  • Biochemical Acid Research Studies
  • Curcumin's Biomedical Applications
  • Glycosylation and Glycoproteins Research
  • Boron Compounds in Chemistry
  • Cutaneous Melanoma Detection and Management

Institute of Gene Biology
2013-2025

Russian Academy of Sciences
2012-2019

Laboratory of Molecular Genetics
2017

Lomonosov Moscow State University
2010-2014

Gamma-ray emitting 111In, which is extensively used for imaging, also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, radionuclides can be as therapeutic anticancer agent if delivered precisely into nuclei tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery cargoes cells are perspective candidates specific intracellular...

10.3389/fphar.2018.01331 article EN cc-by Frontiers in Pharmacology 2018-11-19

This study evaluates the potential utility of a modular nanotransporter (MNT) for enhancing nuclear delivery and cytotoxicity Auger electron emitter 125I in cancer cells that overexpress epidermal growth factor receptor (EGFR).MNTs are recombinant multifunctional polypeptides we have developed achieving selective short-range therapeutics into cells. MNTs contain functional modules binding, internalization, endosomal escape translocation, thereby facilitating transport drugs from cell surface...

10.1186/2191-219x-2-59 article EN cc-by EJNMMI Research 2012-10-29

To compare the effectiveness of various bioactive agents reversibly acting within a cell on target intracellular macromolecule, it is necessary to assess effective cytoplasmic concentrations delivered agents. In this work, based simple equilibrium model and cellular thermal shift assay (CETSA), an approach proposed both agent protein. This was tested by evaluating average nuclear factor erythroid 2-related 2 (Nrf2) Kelch-like ECH-associated-protein 1 (Keap1) proteins in cytoplasm for five...

10.3390/pharmaceutics15020324 article EN cc-by Pharmaceutics 2023-01-18

Brachytherapy, or internal radiation therapy, is a highly effective treatment option for localized tumors. Herein, injectable and biodegradable metal-organic frameworks (MOFs) were engineered to deliver the therapeutic radioisotope yttrium-90 (90Y). Particles of bimetallic MIL-100(Fe,Y) Y-BTC, doped with 90Y 88Y, synthesized in single step retained radioyttrium various buffer solutions. Tumor injectability retention evaluated using tumor-bearing mice. In vivo analysis calculations showed...

10.1039/d4tb02809k article EN Journal of Materials Chemistry B 2025-01-01

Purpose: Modular nanotransporters (MNTs) are artificial multifunctional systems designed to facilitate receptor-specific transport from the cell surface into nucleus through inclusion of polypeptide domains for accomplishing receptor binding and internalization, as well sequential endosomal escape nuclear translocation. The objective this study was develop a new MNT targeted at folate receptors (FRs) precise delivery therapeutic cargo nuclei FR-positive cells evaluate its potential,...

10.2147/dddt.s127270 article EN cc-by-nc Drug Design Development and Therapy 2017-04-01

Purpose: Modular nanotransporters (MNTs) are a polyfunctional platform designed to achieve receptor-specific delivery of short-range therapeutics into the cell nucleus by receptor-mediated endocytosis, endosome escape, and targeted nuclear transport. This study evaluated potential utility MNT in tandem with Auger electron emitting 111 In for cancer therapy. Methods: Three MNTs developed target either melanocortin receptor-1 (MC1R), folate receptor (FR), or epidermal growth factor (EGFR) that...

10.2147/ijn.s125359 article EN cc-by-nc International Journal of Nanomedicine 2017-01-01

Since cell nucleus is one of the most vulnerable compartments, maximum therapeutic effect from a variety locally acting agents, such as photosensitizers, alfa-emitters, Auger electron emitters, will be expected when they get there. Therefore, targeted delivery these agents into nuclei target tumor cells necessary for their anticancer effects and minimization side effects. Modular nanotransporters (MNT) are artificial polypeptides comprising several predefined modules that recognize cell,...

10.3389/fphar.2020.00176 article EN cc-by Frontiers in Pharmacology 2020-03-04

To counteract oxidative stress, antioxidants including carotenoids are highly promising, yet their exploitation is drastically limited by the poor bioavailability and fast photodestruction, whereas current delivery systems far from being efficient. Here we demonstrate that recently discovered nanometer-sized water-soluble carotenoprotein Anabaena sp. PCC 7120 (termed AnaCTDH) transiently interacts with liposomes to efficiently extract via carotenoid-mediated homodimerization, yielding...

10.3390/antiox9090869 article EN cc-by Antioxidants 2020-09-15

The study of oxidative stress in cells and ways to prevent it attract increasing attention. Antioxidant defense can be activated by releasing the transcription factor Nrf2 from a complex with Keap1, its inhibitor protein. aim work was effect modular nanotransporter (MNT) carrying an R1 anti-Keap1 monobody (MNT

10.3390/pharmaceutics16101345 article EN cc-by Pharmaceutics 2024-10-21

Treatment of various diseases, in particular cancer, usually needs targeting biologically active molecules at a selected subcellular compartment. We modified our previously developed modular nanotransporters (MNTs) for mitochondria. The new MNTs are capable binding to the protein predominantly localized on outer mitochondrial membrane, Keap1. These possessing antiKeap1 monobody co-localize with mitochondria upon addition cells. They efficiently interact Keap1 both solution and within living...

10.20944/preprints202311.0337.v1 preprint EN 2023-11-07

Treatment of various diseases, in particular cancer, usually requires the targeting biologically active molecules at a selected subcellular compartment. We modified our previously developed modular nanotransporters (MNTs) for mitochondria. The new MNTs are capable binding to protein predominantly localized on outer mitochondrial membrane, Keap1. These possessing antiKeap1 monobody co-localize with mitochondria upon addition cells. They efficiently interact Keap1 both solution and within...

10.3390/pharmaceutics15122687 article EN cc-by Pharmaceutics 2023-11-27

Abstract Brachytherapy, or intratumoral radiation therapy, is a highly effective treatment option for localized tumors. Herein, we engineered injectable and biodegradable metal-organic frameworks (MOFs) to deliver the therapeutic radioisotope yttrium-90 ( 90 Y). Particles of bimetallic MIL-100(Fe,Y) Y-BTC, doped with Y 88 Y, were synthesized in single step retained radioyttrium various buffer solutions. Tumor injectability retention evaluated using tumor-bearing mice. In vivo analysis...

10.1101/2024.09.14.613012 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2024-09-20
Coming Soon ...